BMI, other markers could address steatotic liver disease screening ‘blind spot’ in youth

CHICAGO — Insulin resistance markers and BMI were more effective in detecting steatotic liver disease among adolescents and young adults compared with glycemic and lipid measurements, according to study results. The data, presented at Digestive Disease Week, showed that BMI, estimated glucose disposal rate (eGDR) and homeostatic model assessment of insulin resistance (HOMA-IR) were